Found 116 matching trials
Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors PHASE1 This is a Phase 1 open-label, multicenter study of the safety and tolerabil...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
GVAX Plus Checkpoint Blockade in Neuroblastoma PHASE1 This research clinical trial is studying the creation and administration of...
Show More Location
Boston Children's Hospital
Learn More & Join Trial
Cryotherapy With in Situ Immunotherapy in Melanoma Metastasis PHASE1 Melanoma is the deadliest form of skin cancer and its incidence has doubled...
Show More Location
Clinique Dermatologique/Radiologie Interventionnelle/Urologie/Gynécologie-CHU de Strasbourg/ICANS
Learn More & Join Trial
Ipilimumab and Nivolumab in Recurrent Extensive Stage Small Cell Lung Cancer After Receiving Platinum-based Chemotherapy PHASE2 This is a pilot study of patients who previously received platinum chemothe...
Show More Status
Active Not Recruiting
Location
Yale University, Yale Cancer Center
Learn More & Join Trial
Melanoma Metastasized to the Brain and Steroids PHASE2 This clinical trial is to clarify whether treatment with a checkpoint inhib...
Show More Location
Herlev Universityhospital
Learn More & Join Trial
COL Immunotherapy Before Radiochimio + Ipilimumab NA This is a multicenter, single arm pilot study evaluating the biological imp...
Show More Location
Centre François Baclesse
Learn More & Join Trial
A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC) PHASE1 The purpose of this study is to determine whether the combination of a neoa...
Show More Location
Johns Hopkins SKCCC
Learn More & Join Trial
Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma PHASE2 TITAN RCC (0216-ASG) is a Phase 2, open-label study of nivolumab monotherap...
Show More Location
Ordensklinikum Linz Barmherzige Schwestern
Learn More & Join Trial
Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response N/A Immunotherapy with agents stimulating the immune system to act against canc...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
Radiation and Combination Immunotherapy for Melanoma PHASE2 This is a Phase 2 study designed to evaluate the combination of checkpoint ...
Show More Location
University of Minnesota Masonic Cancer Center
Learn More & Join Trial